Safety and Efficacy of DNK333 in Atopic Dermatitis Patients
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of DNK333 in patients with atopic dermatitis
suffering from pruritus, who require systemic treatment of the disease.